Agenus, Inc. (AGEN)
6.87
-0.35
(-4.85%)
USD |
NASDAQ |
Nov 12, 16:00
6.81
-0.06
(-0.87%)
After-Hours: 07:32
Agenus Market Cap : 310.58M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 310.58M |
| November 11, 2026 | 326.41M |
| November 10, 2026 | 317.36M |
| November 09, 2026 | 323.24M |
| November 06, 2026 | 323.24M |
| November 05, 2026 | 291.14M |
| November 04, 2026 | 315.10M |
| November 03, 2026 | 301.54M |
| November 02, 2026 | 278.28M |
| October 30, 2026 | 291.49M |
| October 29, 2026 | 302.14M |
| October 28, 2026 | 303.85M |
| October 27, 2026 | 283.39M |
| October 26, 2026 | 262.51M |
| October 23, 2026 | 269.76M |
| October 22, 2026 | 277.43M |
| October 21, 2026 | 272.74M |
| October 20, 2026 | 273.59M |
| October 19, 2026 | 263.36M |
| October 16, 2026 | 257.40M |
| October 15, 2026 | 284.67M |
| October 14, 2026 | 277.00M |
| October 13, 2026 | 296.18M |
| October 12, 2026 | 316.63M |
| October 09, 2026 | 326.86M |
| Date | Value |
|---|---|
| October 08, 2026 | 321.32M |
| October 07, 2026 | 322.60M |
| October 06, 2026 | 319.19M |
| October 05, 2026 | 372.03M |
| October 02, 2026 | 356.27M |
| October 01, 2026 | 354.99M |
| September 30, 2026 | 423.17M |
| September 29, 2026 | 421.47M |
| September 28, 2026 | 401.87M |
| September 25, 2026 | 363.94M |
| September 24, 2026 | 362.23M |
| September 23, 2026 | 357.97M |
| September 22, 2026 | 370.76M |
| September 21, 2026 | 354.99M |
| September 18, 2026 | 334.53M |
| September 17, 2026 | 307.68M |
| September 16, 2026 | 307.26M |
| September 15, 2026 | 305.13M |
| September 14, 2026 | 303.85M |
| September 11, 2026 | 295.75M |
| September 10, 2026 | 293.62M |
| September 09, 2026 | 292.34M |
| September 08, 2026 | 316.63M |
| September 04, 2026 | 351.15M |
| September 03, 2026 | 351.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 11.47B |
| AVITA Medical, Inc. | 501.59M |
| Iovance Biotherapeutics, Inc. | 3.529B |
| Xencor, Inc. | 2.851B |
| Amgen, Inc. | 252.63B |
Market Cap Related Metrics
| PE Ratio | 9.464 |
| PS Ratio | 2.542 |
| Price | 6.87 |
| Earnings Yield | 10.57% |
| Operating PE Ratio | 6.528 |
| Normalized PE Ratio | 5.658 |